Plant Breeding and CRISPR Plants Market Expected to Reach $14.6 billion by 2023 | Key Players Include - Bayer, Syngenta, SGS SA

The report "Plant Breeding and CRISPR Plants Market by Type (Conventional and Biotechnological [Hybrid, Molecular Breeding, GM, Genome Editing]), Trait (Herbicide Tolerance, Disease Resistance, and Yield Improvement), Application, and Region–Global Forecast to 2023" The plant breeding and CRISPR plants market is projected to reach USD 14.6 billion by 2023, from USD 7.6 billion in 2018, at a CAGR of 13.95% during the forecast period. The market is driven by factors such as the growing need for high-quality crops and increased yield, and rising application of plant biotechnology in the agriculture industry.

Make an Inquiry: https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=256910775

Plant breeding techniques for the cereals & grains segment are projected to be widely researched during the forecast period.

Various countries have adopted molecular techniques such as marker-assisted selection (MAS) for plant breeding, due to the increasing demand for high yield from field and horticultural crop growers. Corn is a major crop that finds application in various industries across the world; biotechnological techniques such as hybrid and molecular breeding are increasingly adopted for corn by all breeders. Also, the genetic data available for corn is higher, followed by wheat.

The higher adoption of genetically modified crops such as corn, wheat, and rice in the US, Brazil, and China (only imported for feed purpose) has been a major factor contributing to the growth of the cereals & grains segment in the plant breeding market.

Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=256910775

The molecular breeding segment is projected to witness the fastest growth during the forecast period.

Since the cultivation of GM crops has been adopted in all regions except Europe, the genetic engineering technique is projected to exhibit a sluggish growth in the coming years due to strong regulatory control of its practice in many countries. This holds true for CRISPR technology as well. Though, the technology promised exponential growth while its emergence, regulations by Europe in line with genetic modification, affected the adoption rate of CRISPR technology. However, since the molecular breeding technique is based on molecular markers for trait selection, it is completely unregulated across the globe; hence, the segment has higher growth potential in comparison with all other breeding techniques.

North America is estimated to dominate the market in 2018, while the Asia Pacific is projected to witness the fastest growth through 2023.

The increasing industrial value for corn and soybean in the US has been encouraging breeders to adopt advanced technologies for better yield, owing to which the adoption rate for genetics in this country has been high. Also, the limited regulatory control and high promotional support for intellectual property affairs in genetic technology have been extremely favorable toward the adoption of biotechnological tools in agriculture. Hence, North America dominated the global plant breeding market in 2017. On the other hand, there has been an ever-increasing demand for commercial seeds in the Asian market, in line with the improving economic conditions. Also, seed manufacturers such as Bayer, Monsanto, and Syngenta have been showing increasing interest in tapping this potential market, wherein the companies have been expanding their R&D centers across the Asia Pacific.

This report includes a study of development strategies of leading companies. The scope of this report includes a detailed study of major seed manufacturers that have in-house plant breeding facilities; these companies include players such as Bayer (Germany), Syngenta (Switzerland), DowDuPont (US), KWS SAAT (Germany), Limagrain (France), and DLF Trifolium (Denmark), and also major service providers, such as Eurofins (Luxembourg), SGS SA (Switzerland), Pacific Biosciences (US), Benson Hill Systems (US), Hudson River Biotechnology (US), Evogene (Israel), Bioconsortia (US), and Equinom (Israel).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Shelly Singh
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
sales@marketsandmarkets.com

This release was published on openPR.